Latest News

Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares



BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an update for shareholders with regards to the exchange (the “Exchange”) of preferred share purchase rights (the “Rights”) for the Company’s Common Shares and Series B Convertible Preferred Shares (the “Exchange Shares”), originally announced on February 22, 2019, by press release. On April 4, 2019, the Eastern Caribbean Supreme Cour

Source link

Related posts

Contact Tracer Teams Growing Amid New Challenges

Newsemia

Quick & easy extraction of biological & aqueous samples

Newsemia

Kidney Stone Causes And Best Preventive Measure

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World